Physician profile
Joseph Baylan
NPI 1134431232
$6,400.59
in general payments reported to CMS, 2019-2025
19 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $419 · 2021: $1,636 · 2022: $840 · 2023: $857 · 2024: $876 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,107 · Long Term Medical Supply Or Device Loan: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,106.98 |
| Long Term Medical Supply Or Device Loan | $651.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,546.68 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $837.71 | 2023-2025 | Alloderm, Botox |
| Integra Lifesciences Corporation | $781.60 | 2020-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Sientra, INC. | $741.71 | 2020-2022 | |
| Allergan, INC. | $632.83 | 2019-2022 | |
| Inspire Medical Systems, INC. | $483.68 | 2020-2025 | Inspire |
| Synthes Gmbh | $372.06 | 2019 | |
| Depuy Synthes Sales INC. | $297.52 | 2021-2023 | Matrixmandible |
| Kls-Martin L.P. | $195.26 | 2019-2021 | |
| Medtronic, INC. | $125.93 | 2023-2024 | Situate, Swiftset |
| Stryker Corporation | $107.05 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $85.00 | 2019 | |
| Acclarent, INC | $65.17 | 2019 | |
| Motiva USA, LLC | $41.58 | 2025 | |
| Optinose US, INC. | $20.64 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $19.28 | 2024 | |
| Olympus America INC. | $16.74 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $16.23 | 2021 | |
| Alk-Abello, INC | $13.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Baylan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.